Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors

Park, H; Shapiro, GI; Gao, X; Mahipal, A; Starr, J; Furqan, M; Singh, P; Ahrorov, A; Gandhi, L; Ghosh, A; Hickman, D; Gallacher, PD; Wennborg, A; Attar, EC; Awad, MM; Das, S; Dumbrava, EE

Park, H (通讯作者),Washington Univ, Div Oncol, 660 South Euclid Ave, St Louis, MO 63110 USA.

ESMO OPEN, 2022; 7 (5):